PATENT CLAIM ANALYSIS

Application Number: 15780618
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "675000"]

Abstract:
Provided herein are compounds that act as histone deacetylase (HDAC) inhibitors, and can affect expression of genes in vivo and in vitro. These HDAC inhibitors are generally volatile compounds that can be administered as a gas or vapor. Such inhibitors can be used as therapeutics for numerous disease conditions, such as a variety of cancers, neural degenerative diseases, neurological diseases, senescence, and infectious diseases.

Claim (Index 5):
A method of modulating gene expression in neurons in a subject in need thereof, comprising administering to the subject via inhalation an effective amount of a volatile histone deacetylase (HDAC) inhibitor compound to modulate gene expression in the neurons of the subject.

Metadata:
- Claim Count in Document: 24.0
- Percentile: 93.0
- Lexical Diversity: 1.53061
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15540316', '12285380', '11920909', '15934299', '13747044']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7742574625635634
- 35 USC 102 Novelty (BERT): 0.5062953447770097
- Combined Prediction Score: 0.7474612507849081
- Mean Citation Score: 271.448808
- Max Citation Score: 281.13092
- Similarity Product: 209.1436640855551

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test